What steps should be taken to evaluate and manage a low white blood cell (leukopenia) count?

Evaluation and Management of Low White Blood Cell Count (Leukopenia)

Immediately assess the absolute neutrophil count (ANC) and check for fever—if ANC <0.5 × 10⁹/L with fever >38.5°C, this is febrile neutropenia requiring urgent hospitalization and broad-spectrum antibiotics to prevent mortality. 1, 2

Initial Diagnostic Approach

Critical First Steps

• Review previous blood counts to determine if this is acute or chronic leukopenia and assess the trajectory 2
• Evaluate all three cell lines (WBC, RBC, platelets)—bicytopenia or pancytopenia suggests bone marrow failure rather than isolated leukopenia 2
• Obtain a manual peripheral blood smear to assess differential counts and identify dysplasia or abnormal cells 2

Define the Severity

Neutropenia is the most clinically significant component since neutrophils comprise 50-70% of circulating leukocytes 3:

• Mild neutropenia: ANC 1,000-1,500/mcL
• Moderate neutropenia: ANC 500-1,000/mcL
• Severe neutropenia/agranulocytosis: ANC <500/mcL 3

The absolute neutrophil count matters more than the total WBC count for infection risk. 3

Immediate Management Based on Clinical Presentation

If Febrile with Severe Neutropenia (ANC <0.5 × 10⁹/L)

• Immediate hospital admission is mandatory 2
• Start broad-spectrum antibiotics immediately before completing diagnostic workup to reduce mortality 1, 2
• Febrile neutropenia is defined as axillary temperature >38.5°C for >1 hour with ANC <0.5 × 10⁹/L 1

If Afebrile or Mild-Moderate Neutropenia

• Assess chronicity: Determine if transient versus chronic (>3 months) 3
• Identify extrinsic causes: Medications (antiepileptics, chemotherapy), infections, autoimmune conditions, nutritional deficiencies 3, 4
• Consider intrinsic causes: Bone marrow disorders if other cell lines affected or no clear extrinsic cause 3

Specific Clinical Scenarios

Drug-Induced Leukopenia

For patients on antiepileptic drugs with chronic stable leukopenia (WBC 2,000-4,000/mcL):

• Continuation of therapy is probably safe if the leukopenia is stable and the percentage of neutrophils is normal 4
• Exercise caution if absolute neutrophil count consistently <1,000/mcL 4
• Bone marrow examination is not routinely needed if leukopenia fluctuates in the 2,000-4,000 range 4

Chemotherapy-Related Leukopenia

• Do NOT use G-CSF or other hematopoietic growth factors for standard-dose chemotherapy unless specific high-risk criteria are met 1
• G-CSF is contraindicated during chest radiotherapy due to increased complications and death 1
• Primary prophylaxis with growth factors is only indicated for regimens with high febrile neutropenia risk 1

Key Diagnostic Pitfalls to Avoid

• Severe leukopenia (WBC ≤2,500/mcL) in febrile infants is associated with invasive bacterial infections, but if procalcitonin is available and ≤0.5 ng/mL, no patients had infections 5
• Do not rely solely on WBC count trends after packed cell transfusions in septic patients—transfusions cause only mild decreases in WBC (mean 0.45 × 10⁹/L) that are not clinically significant 6
• In immunocompromised patients with low CSF WBC counts, serious infections can still occur despite normal cell counts, unlike in immunocompetent patients 7

When to Perform Bone Marrow Examination

• Pancytopenia or bicytopenia suggesting marrow failure 2
• Persistent unexplained neutropenia without clear extrinsic cause 3
• Dysplasia noted on peripheral smear 2
• NOT routinely needed for stable drug-induced leukopenia in the 2,000-4,000 range 4